Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
145.83
+0.24 (0.16%)
At close: Nov 20, 2026, 4:00 PM EST
147.88
+2.05 (1.41%)
After-hours: Nov 20, 2026, 7:50 PM EST
Guardant Health Revenue
Guardant Health had revenue of $360.98M in the quarter ending September 30, 2026, with 36.12% growth. This brings the company's total for the last twelve months to $1.28B, up 41.69% year-over-year. In the year 2025, Guardant Health had annual revenue of $982.02M with 32.88% growth. That makes Guardant Health the 6,637th largest company in the world by revenue and 1,635th in the United States.
Revenue (ttm)
$1.28B
Revenue Growth
+41.69%
P/S Ratio
15.43
Revenue / Employee
$510,329
Employees
2,506
Market Cap
19.73B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Guardant Health breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 982.02M | 243.01M | 32.88% |
| Dec 31, 2024 | 739.02M | 175.07M | 31.04% |
| Dec 31, 2023 | 563.95M | 114.41M | 25.45% |
| Dec 31, 2022 | 449.54M | 75.89M | 20.31% |
| Dec 31, 2021 | 373.65M | 86.92M | 30.32% |
| Dec 31, 2020 | 286.73M | 72.36M | 33.75% |
| Dec 31, 2019 | 214.38M | 123.74M | 136.52% |
| Dec 31, 2018 | 90.64M | 40.80M | 81.85% |
| Dec 31, 2017 | 49.84M | 24.59M | 97.40% |
| Dec 31, 2016 | 25.25M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| IQVIA Holdings | 17.31B |
| Labcorp Holdings | 14.59B |
| Quest Diagnostics | 11.84B |
| ICON Public Limited Company | 8.23B |
| Illumina | 4.54B |
| Mettler-Toledo International | 4.20B |
| Charles River Laboratories International | 3.98B |
| Revvity | 2.94B |
GH News
- 2 days ago - Guardant Health Launches Guardant Reveal® Ultra to Deliver Leading Sensitivity in MRD Testing - Business Wire
- 3 days ago - Guardant Health Transcript: Jefferies Global Healthcare Conference - Transcripts
- 8 days ago - Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 10 days ago - Guardant Health Prices $500 Million Convertible Senior Notes Offering - Business Wire
- 10 days ago - Guardant Health Announces Proposed $500.0 Million Offering of Convertible Senior Notes Due 2032 - Business Wire
- 10 days ago - Guardant Health announces new applications for Guardant360 Liquid - TheFly
- 10 days ago - Guardant Health Introduces New Epigenomic Applications Providing Deeper Insights for Treatment Selection with Guardant360® Liquid - Business Wire
- 11 days ago - Guardant Health ESMO study highlights utility of Guardant 360 - TheFly